{"id":12771,"date":"2022-12-16T12:44:53","date_gmt":"2022-12-16T11:44:53","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12771"},"modified":"2026-03-03T09:52:01","modified_gmt":"2026-03-03T08:52:01","slug":"gute-nachrichten-fuer-den-produktionsstandort-schweiz","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/","title":{"rendered":"Press release: <strong>Good news for Switzerland\u2019s standing as a production center<\/strong>"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>Interpharma welcomes the approval of the Sectoral Agreement on Mutual Recognition of Inspection results with the US by the Federal Council.<\/strong><\/p>\n\n\n\n<p>Interpharma welcomes the approval by the Federal Council of the Sectoral Agreement on Mutual Recognition of Inspection results between Switzerland and the US (GMP MRA). This is good news for Switzerland as a production center and the security of supply in Switzerland. The agreement enables Switzerland and the US, two countries with high safety and quality standards, to dispense with cost-intensive mutual inspections of production sites in the field of \u201cgood production practices.\u201d The approval of medicines for Switzerland is unaffected by the agreement and will continue to be conducted and issued by Swissmedic.<\/p>\n\n\n\n<p>The US is the second-biggest trade partner for research-based pharmaceutical companies in Switzerland. With total exports of pharmaceutical products of CHF 109 billion and imports of CHF 41 billion, the US share accounts for 26 percent and 10 percent of the total, respectively. Since 2012, pharmaceutical exports to the US and imports from the US have risen by 14 percent and 4 percent, respectively.<\/p>\n\n\n\n<p>The agreement eases trade between the two countries by reducing the associated financial and administrative burden: the inspection of a plant or certification of a production batch obliges companies to dedicate considerable human and financial resources. The agreement will now free those resources up for innovative activities. The regulation authority will be able to avoid travel, focus on domestic inspections and take advantage of synergies and learning effects through the interaction with producers.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strengthening-security-of-supply\"><strong>Strengthening security of supply<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>In concrete terms, the agreement\u2019s elimination of non-tariff trade barriers means that Swissmedic and the US <em>Food and Drug Administration<\/em> (FDA), after intensive evaluation of each others\u2019 inspection practices, will henceforth dispense with inspections of the production sites of drug manufacturers in the respective other country. They will receive the inspection results of the partner and evaluate the quality of the manufacturing system of the companies producing on this base. The applicable regulatory requirements for approval of drugs in Switzerland and the US will remain unchanged by this simplifying measure.<\/p>\n\n\n\n<p>The agreement strengthens the security of supply in Switzerland as it contributes to the resilience of global supply chains. It also puts Switzerland on an equal footing with the EU and the UK, which have already concluded comparable agreements with the US.<\/p>\n\n\n\n<p class=\"is-style-paragraph-lead-text\"><strong>Interpharma salue l\u2019acceptation par le Conseil f\u00e9d\u00e9ral de l\u2019accord avec les \u00c9tats-Unis sur la reconnaissance mutuelle des r\u00e9sultats d\u2019inspections.<\/strong><\/p>\n\n\n\n<p>Interpharma salue l\u2019acceptation par le Conseil f\u00e9d\u00e9ral de l\u2019accord avec les \u00c9tats-Unis sur la reconnaissance mutuelle des r\u00e9sultats d\u2019inspections (GMP MRA). Les \u00c9tats-Unis sont le deuxi\u00e8me partenaire commercial des entreprises pharmaceutiques pratiquant la recherche en Suisse. Sur 109&nbsp;milliards de francs d\u2019exportations de produits pharmaceutiques et 41&nbsp;milliards de francs d\u2019importations au total, les \u00c9tats-Unis repr\u00e9sentent respectivement 26% et 10%. Depuis 2012, les exportations de produits pharmaceutiques vers les \u00c9tats-Unis et les importations en provenance des \u00c9tats-Unis ont augment\u00e9 respectivement de 14% et 4% en moyenne.<\/p>\n\n\n\n<p>L\u2019accord facilite le commerce entre les deux pays, car il r\u00e9duit le travail et les frais administratifs: l\u2019inspection d\u2019un site de production ou la certification d\u2019un lot de produits sollicite beaucoup de ressources personnelles et financi\u00e8res de l\u2019entreprise que la conclusion de l\u2019accord lib\u00e8re pour les activit\u00e9s innovantes. Les autorit\u00e9s de r\u00e9gulation peuvent s\u2019\u00e9pargner des voyages, se concentrer sur les inspections dans leur propre pays et, par l\u2019interaction avec les fabricants pr\u00e9sents sur leur march\u00e9, utiliser des synergies et tirer des enseignements.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Renforcement de la s\u00e9curit\u00e9 d\u2019approvisionnement<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>L\u2019\u00e9limination par l\u2019accord des obstacles non tarifaires au commerce signifie concr\u00e8tement que Swissmedic et la <em>Food and Drug Administration<\/em> (FDA) am\u00e9ricaine, apr\u00e8s contr\u00f4le soigneux des pratiques d\u2019inspection de l\u2019\u00c9tat partenaire, renoncent mutuellement \u00e0 inspecter les sites de production des fabricants de produits pharmaceutiques de l\u2019autre pays. Les deux autorit\u00e9s re\u00e7oivent les r\u00e9sultats des inspections du partenaire et \u00e9valuent la qualit\u00e9 du syst\u00e8me de fabrication den entreprises productrices sur cette base. Cette simplification n\u2019affecte pas les exigences r\u00e8glementaires pos\u00e9es \u00e0 l\u2019autorisation de mise sur le march\u00e9 des m\u00e9dicaments en Suisse et aux \u00c9tats-Unis.<\/p>\n\n\n\n<p>L\u2019accord renforce la s\u00e9curit\u00e9 d\u2019approvisionnement en Suisse, car il contribue \u00e0 la r\u00e9silience des cha\u00eenes d\u2019approvisionnement mondiales. Par ailleurs, cela veut dire que dans le secteur concern\u00e9 par cet accord, la Suisse sera \u00e0 l\u2019avenir sur un pied d\u2019\u00e9galit\u00e9 avec l\u2019UE et le Royaume-Uni qui ont d\u00e9j\u00e0 conclu des accords similaires avec les \u00c9tats-Unis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Interpharma welcomes the approval of the Sectoral Agreement on Mutual Recognition of Inspection results with the US by the Federal Council. Interpharma welcomes the approval by the Federal Council of the Sectoral Agreement on Mutual Recognition of Inspection results between Switzerland and the US (GMP MRA). This is good news for Switzerland as a production [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2565,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[129],"class_list":["post-12771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-pharmastandort-2030-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Press release: Good news for Switzerland\u2019s standing as a production center - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press release: Good news for Switzerland\u2019s standing as a production center\" \/>\n<meta property=\"og:description\" content=\"Interpharma welcomes the approval of the Sectoral Agreement on Mutual Recognition of Inspection results with the US by the Federal Council. Interpharma welcomes the approval by the Federal Council of the Sectoral Agreement on Mutual Recognition of Inspection results between Switzerland and the US (GMP MRA). This is good news for Switzerland as a production [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-16T11:44:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:52:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1731\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Press release: Good news for Switzerland\u2019s standing as a production center\",\"datePublished\":\"2022-12-16T11:44:53+00:00\",\"dateModified\":\"2026-03-03T08:52:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\"},\"wordCount\":784,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg\",\"keywords\":[\"Pharmastandort 2030\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\",\"url\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\",\"name\":\"Press release: Good news for Switzerland\u2019s standing as a production center - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg\",\"datePublished\":\"2022-12-16T11:44:53+00:00\",\"dateModified\":\"2026-03-03T08:52:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg\",\"width\":2560,\"height\":1731},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release: Good news for Switzerland\u2019s standing as a production center\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Press release: Good news for Switzerland\u2019s standing as a production center - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/","og_locale":"en_US","og_type":"article","og_title":"Press release: Good news for Switzerland\u2019s standing as a production center","og_description":"Interpharma welcomes the approval of the Sectoral Agreement on Mutual Recognition of Inspection results with the US by the Federal Council. Interpharma welcomes the approval by the Federal Council of the Sectoral Agreement on Mutual Recognition of Inspection results between Switzerland and the US (GMP MRA). This is good news for Switzerland as a production [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/","og_site_name":"Interpharma","article_published_time":"2022-12-16T11:44:53+00:00","article_modified_time":"2026-03-03T08:52:01+00:00","og_image":[{"width":2560,"height":1731,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"berta_admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Press release: Good news for Switzerland\u2019s standing as a production center","datePublished":"2022-12-16T11:44:53+00:00","dateModified":"2026-03-03T08:52:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/"},"wordCount":784,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg","keywords":["Pharmastandort 2030"],"inLanguage":"en-US","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/","url":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/","name":"Press release: Good news for Switzerland\u2019s standing as a production center - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg","datePublished":"2022-12-16T11:44:53+00:00","dateModified":"2026-03-03T08:52:01+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/12\/CH-USA-scaled.jpg","width":2560,"height":1731},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/blog\/gute-nachrichten-fuer-den-produktionsstandort-schweiz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Press release: Good news for Switzerland\u2019s standing as a production center"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=12771"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12771\/revisions"}],"predecessor-version":[{"id":12772,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/12771\/revisions\/12772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/2565"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=12771"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=12771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}